Related references
Note: Only part of the references are listed.Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing
Thijs J. van de Laar et al.
TRANSFUSION (2021)
Hepatitis B virus prevalence in first-time blood donors in Flanders, Belgium: Impact of universal vaccination and migration
Niels De Brier et al.
TRANSFUSION (2021)
Hepatitis B infections among blood donors in England between 2009 and 2018: Is an occult hepatitis B infection a risk for blood safety?
Heli Harvala et al.
TRANSFUSION (2021)
Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country [Transfus Med Hemother. 2019 Apr;46(2):104-10]
Claire E. Styles et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2020)
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection
Gian Paolo Caviglia et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2020)
Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose
Daniel Candotti et al.
GUT (2019)
Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country
Martin Stolz et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
Update of the statements on biology and clinical impact of occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2019)
Anti-HBc screening - is it worth the effort? Results of a 10-year surveillance programme covering more than 30 million donations in Germany
Claudia Houareau et al.
VOX SANGUINIS (2019)
Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015)
Sarah A. Fiedler et al.
VOX SANGUINIS (2019)
Reduction of acute hepatitis B through vaccination of adolescents with no decrease in chronic hepatitis B due to immigration in a low endemicity country
Jean-Luc Richard et al.
SWISS MEDICAL WEEKLY (2017)
A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios
Jos Weusten et al.
TRANSFUSION (2017)
Occult hepatitis B infection and transfusion-transmission risk
D. Candotti et al.
TRANSFUSION CLINIQUE ET BIOLOGIQUE (2017)
Rare transmission of hepatitis B virus by Dutch donors with occult infection
Ryanne W. Lieshout-Krikke et al.
TRANSFUSION (2016)
The yield of universal antibody to hepatitisB core antigen donor screening in the Netherlands, a hepatitisB virus low-endemic country
Thijs J. van de Laar et al.
TRANSFUSION (2015)
Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme
C. R. Seed et al.
VOX SANGUINIS (2015)
Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection
Philip Kiely et al.
TRANSFUSION (2014)
Infectivity of blood products from donors with occult hepatitis B virus infection
Jean-Pierre Allain et al.
TRANSFUSION (2013)
Simple confirmatory assay for anti-HBc reactivity
Daniela Huzly et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™
Johannes Irsch et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2011)
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region
Martin Stolz et al.
TRANSFUSION (2010)
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT
V. K. S. Leung et al.
TRANSFUSION MEDICINE (2010)
Fatal outcome of a hepatitis B virus transfusion-transmitted infection
C. Niederhauser et al.
VOX SANGUINIS (2010)
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2008)
Hepatitis B virus infection and transfusion medicine: science and the occult
F. Blaine Hollinger
TRANSFUSION (2008)
Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience
Sheila F. O'Brien et al.
TRANSFUSION (2007)
Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program
Masahiro Satake et al.
TRANSFUSION (2007)
Share Paper
